Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Agile Therapeutics, Inc.

TRADE

NASDAQ: AGRXHealthcare / Drugs - Generic / USA
0.36-0.01-2.70%Vol 2 533 7501Y Perf -90.35%
Sep 18th, 2018 16:00
BID0.34 ASK0.37
Open0.38 Previous Close0.37
Pre-Market0.36 After-Trading-
 -0.01 -2.70%  - -%
Target Price
2.44 
Analyst Rating
Moderate Buy 2.25
Potencial %
577.78 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)12 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
2.51 
Earnings Date
5th Nov 2018

Today's Price Range

0.320.38

 

52wk Range

0.235.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
48.00%
3 Months
-35.09%
6 Months
-87.79%
1 Year
-90.35%
3 Years
-95.38%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
AGRX0.36-0.0100-2.70
AAPL218.240.36000.17
GOOG1 161.225.17000.45
MSFT113.211.07000.95
XOM83.630.22000.26
WFC54.500.19000.35
JNJ140.540.58000.41
FB160.30-0.2800-0.17
GE12.66-0.0400-0.31
JPM114.300.46000.40
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.20
Current Ratio 2.20
Long Term Debt to Total Capital 0.12
Total Debt to Equity 0.29
Interest Coverage -15.70
Leverage Ratio 1.40
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 0.47
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -0.50
Cash Flow Per Share -0.67
Price to Tangible Book0.47
Book Value per Share0.76
Enterprise Value (in ths.)-2 495
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-267.72
ROE last 12 Months -91.05
Return on Assets (5Y Avg) -56.43
ROA last 12 Months -60.10
Return on Capital (5Y Avg) -
ROC last 12 Months -70.70
Return on invested Capital Q -13.96
Return on invested Capital Y-56.55
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.17-0.165.88
Q01 2018-0.19-0.21-10.53
Q04 2017-0.23-0.1821.74
Q03 2017-0.25-0.2212.00
Q02 2017-0.28-0.267.14
Q01 2017-0.31-0.2616.13
Q04 2016-0.27-0.29-7.41
Q03 2016-0.35-0.2722.86
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.1734.62Positive
9/2018 QR-0.1644.83Positive
12/2018 FY-0.6817.07Positive
12/2019 FY-0.724.00Positive
Next Report Date5th Nov 2018
Estimated EPS Next Report-0.16
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume2 533 750
Shares Outstanding (in ths.)34 380
Trades Count2 033
Dollar Volume835 386
Avg. Volume846 013
Avg. Weekly Volume4 874 520
Avg. Monthly Volume4 270 750
Avg. Quarterly Volume1 636 673

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

60%40%

Bearish Bullish

66%34%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (25.00 %)
1 (25.00 %)
2 (40.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (20.00 %)
Hold
2 (50.00 %)
2 (50.00 %)
2 (40.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.25
Moderate Buy
2.25
Moderate Buy
2.00

There are no comments yet.

News

x